Product logins

Find logins to all Clarivate products below.


Trauma Devices – Market Insights – Latin America (Supplemental)

The Latin American trauma device market is poised for significant growth, primarily driven by the expansion of specific high-volume segments. This growth is further supported by the increasing aging population, improved reimbursement policies, and strategic M&A of companies with complementary offerings across the region. In addition, rising patient awareness and enhanced surgical training will boost demand for premium-priced devices. However, the adoption of these advanced products may be somewhat limited by hospital budget constraints.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for trauma devices in Latin America from 2019 through 2033.

Table of contents


Related Medtech Insights Reports

Report
Trauma Devices – Market Insights – United States
Long-term growth of the US trauma device market will be driven by the uptake of novel technologies such as 3-D printed implants, the expansion of the foot and ankle device segment, site-of-service…
Report
Peripheral Vascular Devices – Market Insights – Europe
The European PV device market will be mainly driven by the increasing availability of premium-priced products and emerging products which, supported by clinical data, will increase the penetration…
Report
Peripheral Vascular Devices – Market Insights – United States
The US PV device market will be primarily driven by product innovation, novel technologies, and adoption of premium solutions. However, barriers such as the push for cost-effective PV interventions…
Report
Transcatheter Embolization and Occlusion Devices – Market Insights – United States
The US TEO device market is expected to grow, supported by the approval of new product types within existing indications, entry of new players into different device segments, and favorable changes…
Report
Diabetes Care Devices – Market Insights – United States
The US diabetes care device market will see strong growth over the forecast period, spurred by various factors, namely FDA approvals for new products with expanded indications, strong growth in…